|
1
|
Khan SA, Toledano MB and Taylor-Robinson
SD: Epidemiology, risk factors, and pathogenesis of
cholangiocarcinoma. HPB (Oxford). 10:77–82. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Skipworth JR, Keane MG and Pereira SP:
Update on the management of cholangiocarcinoma. Dig Dis.
32:570–578. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hemming AW, Reed AI, Fujita S, Foley DP
and Howard RJ: Surgical management of hilar cholangiocarcinoma. Ann
Sur. 241:693–702. 2005. View Article : Google Scholar
|
|
4
|
Guthrie CM, Banting SW, Garden OJ and
Carter DC: Segment III cholangiojejunostomy for palliation of
malignant hilar obstruction. Br J Surg. 81:1639–1641. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hassoun Z, Gores GJ and Rosen CB:
Preliminary experience with liver transplantation in selected
patients with unresectable hilar cholangiocarcinoma. Surg Oncol
Clin N Am. 11:909–921. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Petrowsky H and Hong JC: Current surgical
management of hilar and intrahepatic cholangiocarcinoma: The role
of resection and orthotopic liver transplantation. Transplant Proc.
41:4023–4035. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ghali P, Marotta PJ, Yoshida EM, Bain VG,
Marleau D, Peltekian K, Metrakos P and Deschênes M: Liver
transplantation for incidental cholangiocarcinoma: Analysis of the
Canadian experience. Liver Transpl. 11:1412–1416. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Robles R, Figueras J, Turrion VS, Margarit
C, Moya A, Varo E, Calleja J, Valdivieso A, Valdecasas JC, López P,
et al: Spanish experience in liver transplantation for hilar and
peripheral cholangiocarcinoma. Ann Surg. 239:265–271. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Meyer CG, Penn I and James L: Liver
transplantation for cholangiocarcinoma: Results in 207 patients.
Transplantation. 69:1633–1637. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rea DJ, Heimbach JK, Rosen CB, Haddock MG,
Alberts SR, Kremers WK, Gores GJ and Nagorney DM: Liver
transplantation with neoadjuvant chemoradiation is more effective
than resection for hilar cholangiocarcinoma. Ann Surg. 242:451–461.
2005.PubMed/NCBI
|
|
11
|
Gores GJ, Gish RG, Sudan D and Rosen CB:
MELD Exception Study Group: Model for end-stage liver disease
(MELD) exception for cholangiocarcinoma or biliary dysplasia. Liver
Transpl (١٢ Suppl ٣). S95–S97. 2006. View
Article : Google Scholar
|
|
12
|
Darwish Murad S, Kim WR, Harnois DM,
Douglas DD, Burton J, Kulik LM, Botha JF, Mezrich JD, Chapman WC,
Schwartz JJ, et al: Efficacy of neoadjuvant chemoradiation,
followed by liver transplantation, for perihilar cholangiocarcinoma
at 12 US centers. Gastroenterology. 143:88–98, e3; quiz e14. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Paul A, Kaiser GM, Molmenti EP, Schroeder
T, Vernadakis S, Oezcelik A, Baba HA, Cicinnati VR and Sotiropoulos
GC: Klatskin tumors and the accuracy of the Bismuth-Corlette
classification. Am Surg. 77:1695–1699. 2011.PubMed/NCBI
|
|
14
|
Razumilava N and Gores GJ: Classification,
diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol
Hepatol. 11:13–21.e1; quiz e3-e4. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Todoroki T, Kawamoto T, Koike N, Takahashi
H, Yoshida S, Kashiwagi H, Takada Y, Otsuka M and Fukao K: Radical
resection of hilar bile duct carcinoma and predictors of survival.
Br J Surg. 87:306–313. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Klempnauer J, Ridder GJ, von Wasielewski
R, Werner M, Weimann A and Pichlmayr R: Resectional surgery of
hilar cholangiocarcinoma: A multivariate analysis of prognostic
factors. J Clin Oncol. 15:947–954. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakeeb A, Pitt HA, Sohn TA, Coleman J,
Abrams RA, Piantadosi S, Hruban RH, Lillemoe KD, Yeo CJ and Cameron
JL: Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and
distal tumors. Ann Surg. 224:463–465. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu Y, Johlin FC, Rayhill SC, Jensen CS,
Xie J, Cohen MB and Mitros FA: Long-term, tumor-free survival after
radiotherapy combining hepatectomy-Whipple en bloc and orthotopic
liver transplantation for early-stage hilar cholangiocarcinoma.
Liver Transpl. 14:279–286. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Neuhaus P, Jonas S, Bechstein WO, Lohmann
R, Radke C, Kling N, Wex C, Lobeck H and Hintze R: Extended
resections for hilar cholangiocarcinoma. Ann Surg. 230:808–819.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alessiani M, Tzakis A, Todo S, Demetris
AJ, Fung JJ and Starzl TE: Assessment of five-year experience with
abdominal organ cluster transplantation. J Am Coll Surg. 180:1–9.
1995.PubMed/NCBI
|
|
21
|
Zardavas D and Piccart M: Neoadjuvant
therapy for breast cancer. Ann Rev Med. 66:31–48. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kelsen D: Neoadjuvant therapy for
gastrointestinal cancers. Oncol (Williston Park).
7:25-32-411993.
|
|
23
|
Sudan D, DeRoover A, Chinnakotla S, Fox I,
Shaw B Jr, McCashland T, Sorrell M, Tempero M and Langnas A:
Radiochemotherapy and transplantation allow long-term survival for
nonresectable hilar cholangiocarcinoma. Am J Transplant. 2:774–779.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Darwish Murad S, Kim WR, Therneau T, Gores
GJ, Rosen CB, Martenson JA, Alberts SR and Heimbach JK: Predictors
of pretransplant dropout and posttransplant recurrence in patients
with perihilar cholangiocarcinoma. Hepatology. 56:972–981. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hong JC, Jones CM, Duffy JP, Petrowsky H,
Farmer DG, French S, Finn R, Durazo FA, Saab S, Tong MJ, et al:
Comparative analysis of resection and liver transplantation for
intrahepatic and hilar cholangiocarcinoma: A 24-year experience in
a single center. Arch Surg. 146:683–689. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gringeri E, Bassi D, D'Amico FE, Boetto R,
Polacco M, Lodo E, D'Amico F, Vitale A, Boccagni P, Zanus G and
Cillo U: Neoadjuvant therapy protocol and liver transplantation in
combination with pancreatoduodenectomy for the treatment of hilar
cholangiocarcinoma occurring in a case of primary sclerosing
cholangitis: Case report with a more than 8-year disease-free
survival. Transplant Proc. 43:1187–1189. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schule S, Altendorf-Hofmann A, Utess F,
Uteß F, Rauchfuß F, Freesmeyer M, Knösel T, Dittmar Y and
Settmacher U: Liver transplantation for hilar cholangiocarcinoma--a
single-centre experience. Langenbecks Arch Surg. 398:71–77. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gu J, Bai J, Shi X, Zhou J, Qiu Y, Wu Y,
Jiang C, Sun X, Xu F, Zhang Y and Ding Y: Efficacy and safety of
liver transplantation in patients with cholangiocarcinoma: A
systematic review and meta-analysis. Int J Cancer. 130:2155–2163.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Heimbach JK, Gores GJ, Haddock MG, Alberts
SR, Pedersen R, Kremers W, Nyberg SL, Ishitani MB and Rosen CB:
Predictors of disease recurrence following neoadjuvant
chemoradiotherapy and liver transplantation for unresectable
perihilar cholangiocarcinoma. Transplantation. 82:1703–1707. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kelley RK, Hirose R and Venook AP: Can we
cure cholangiocarcinoma with neoadjuvant chemoradiation and liver
transplantation? Time for a multicenter trial. Liver Transpl.
18:509–513. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu Y, Liu JL, Cai ZZ, Lu Z, Gong YF, Wu
HY, Man XH, Jin ZD and Li ZS: A novel approach for treatment of
unresectable extrahepatic bile duct carcinoma: design of
radioactive stents and an experimental trial in healthy pigs.
Gastrointest Endosc. 69:517–524. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu Y, Lu Z, Zou DW, Jin ZD, Liu F, Li SD,
Zhan XB, Zhang WJ, Wu RP, Yao YZ, et al: Intraluminal implantation
of radioactive stents for treatment of primary carcinomas of the
peripancreatic-head region: a pilot study. Gastrointest Endosc.
69:1067–1073. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sgourakis G, Radtke A, Fouzas I, Mylona S,
Goumas K, Gockel I, Lang H and Karaliotas C: Corticosteroid-free
immunosuppression in liver transplantation: a meta-analysis and
meta-regression of outcomes. Transpl Int. 22:892–905. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guba M, von Breitenbuch P, Steinbauer M,
Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S,
Anthuber M, et al: Rapamycin inhibits primary and metastatic tumor
growth by antiangiogenesis: involvement of vascular endothelial
growth factor. Nat Med. 8:128–135. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bruix J and Sherman M: Practice Guidelines
Committee, American Association for the Study of Liver Diseases:
Management of hepatocellular carcinoma. Hepatology. 42:1208–1236.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Klintmalm G and O'Farrelly C: Taking the
rap: Multiple effects of blocking mammalian target of rapamycin.
Hepatology. 57:1–3. 2013. View Article : Google Scholar : PubMed/NCBI
|
